These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23090734)

  • 1. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein.
    Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M
    Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers.
    Wang WQ; Merriam DL; Moses AS; Francis GA
    J Biol Chem; 1998 Jul; 273(28):17391-8. PubMed ID: 9651324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.
    Lagrost L; Perségol L; Lallemant C; Gambert P
    J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduction of lipoproteins with apoAI but without apoAII (LpAI) in non-insulin-dependent diabetic patients].
    Barkia A; Zouari N; Khrouf W; Ellouz F; Zouaghi H
    Ann Biol Clin (Paris); 1996; 54(2):83-6. PubMed ID: 8763631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.
    Gillard BK; Bassett GR; Gotto AM; Rosales C; Pownall HJ
    J Biol Chem; 2017 May; 292(21):8864-8873. PubMed ID: 28373285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris.
    Perez-Mendez O; Bruckert E; Franceschini G; Duhal N; Lacroix B; Bonte JP; Sirtori C; Fruchart JC; Turpin G; Luc G
    Atherosclerosis; 2000 Feb; 148(2):317-25. PubMed ID: 10657568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I.
    Tanaka Y; Ando Y; Kumamoto T; Miyazaki A; Nakamura M; Nakayama M; Araki S; Ando M
    Biochim Biophys Acta; 1994 Feb; 1225(3):311-6. PubMed ID: 8312379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.
    Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R
    J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.
    Gottrand F; Beghin L; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Eur J Clin Invest; 1999 May; 29(5):387-94. PubMed ID: 10354195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol.
    Garner B; Witting PK; Waldeck AR; Christison JK; Raftery M; Stocker R
    J Biol Chem; 1998 Mar; 273(11):6080-7. PubMed ID: 9497325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits.
    Koike T; Koike Y; Yang D; Guo Y; Rom O; Song J; Xu J; Chen Y; Wang Y; Zhu T; Garcia-Barrio MT; Fan J; Chen YE; Zhang J
    Atherosclerosis; 2021 Jan; 316():32-40. PubMed ID: 33296791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
    Holvoet P; Danloy S; Collen D
    Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
    Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
    Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study.
    Wilkins JT; Seckler HS; Rink J; Compton PD; Fornelli L; Thaxton CS; LeDuc R; Jacobs D; Doubleday PF; Sniderman A; Lloyd-Jones DM; Kelleher NL
    J Am Heart Assoc; 2021 Sep; 10(17):e019890. PubMed ID: 34472376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma apolipoprotein AI and AII concentrations in murine reactive amyloidosis.
    Yamada T; Wada A; Fukuda T; Itoh Y; Itoh K
    Scand J Immunol; 1999 Nov; 50(5):475-8. PubMed ID: 10564549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased affinity of apolipoprotein AII to high-density lipoprotein in patients with transthyretin-related amyloidosis (Met30, Gln89, Pro36, and Thr34).
    Nakamura M; Tanaka Y; Ando Y; Yamashita T; Salvi F; Ferlini A; Gobbi P; Patrosso C; Uchino M; Ando M
    Biochem Biophys Res Commun; 1996 Feb; 219(2):316-21. PubMed ID: 8604984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.